Introduction {#s1}
============

Stem cell proliferation and differentiation throughout plant life is regulated by a feedback loop between the homeodomain transcription factor *WUS* and *CLV* ligand-receptor signaling ([@bib48]; [@bib8]; [@bib69]; [@bib87]; [@bib15]). The secretion of the diffusible glycopeptide CLV3 from the central zone (CZ) stem cells of the SAM is believed to initiate signaling through LRR receptors ([@bib23]; [@bib68]; [@bib39]; [@bib64]; [@bib58]), which transmits the signal to restrict the expression of WUS in the organizing center (OC) cells. To balance this system, WUS non-cell-autonomously promotes stem cell fate by activation of *CLV3* expression ([@bib87]; [@bib15]). CLV3 is thought to be perceived by multiple receptor kinase and receptor like proteins, including the CLV1 LRR receptor-like kinase ([@bib11]; [@bib12]; [@bib8]; [@bib62]) and the related BAM receptors ([@bib16]; [@bib17]; [@bib59]; [@bib70]), or by a heterodimer of the receptor like protein CLV2 and the transmembrane pseudokinase CRN ([@bib36]; [@bib32]; [@bib51]; [@bib54]; [@bib3]; [@bib89]; [@bib57]), or by the receptor-like kinase RPK2 ([@bib52]; [@bib61]; [@bib38]). The relationship between CLV1 and CLV2 is not clear- CLV1 can form homodimers, or higher order complexes with CLV2/CRN, to signal co-operatively in the SAM ([@bib26]; [@bib72]), but it seems that CLV2/CRN is not essential for CLV3 perception or for CLV1 signaling ([@bib54]; [@bib58]; [@bib60]). In contrast to CLV1, CLV2 does not bind CLV3 peptide directly ([@bib70]), and its expression is not restricted to the SAM, suggesting that it might function as a co-receptor in additional pathways beyond CLV3 signaling. Indeed, CLV2 appears to be involved in signaling by several CLE peptides ([@bib21]; [@bib50]; [@bib28]) and in biotic interactions ([@bib67]; [@bib27]), suggesting it plays diverse functions in plant development and immunity ([@bib66]). The multiple roles of CLV2 promote the question of how it confers signal specificity. Two candidate downstream effectors of CLV2 have been identified. One is the transmembrane pseudokinase CRN, discovered in *Arabidopsis,* and the second is COMPACT PLANT2 (CT2), the heterotrimeric G protein alpha subunit, discovered in maize ([@bib4]). However, since CRN and CT2 were identified in different species, their molecular and genetic interactions remain unknown.

The CLV-WUS pathway is widely conserved ([@bib71]; [@bib73]). In maize, *THICK TASSEL DWARF1* (*TD1*) and *FEA2* are *CLV1* and *CLV2* orthologs, and function similarly to restrict inflorescence shoot meristem proliferation ([@bib81]; [@bib5]). Two maize WUS orthologs, ZmWUS1 and ZmWUS2, have been predicted by phylogenetic analysis, and a *ZmWUS1* reporter is expressed in the presumptive organizing center of the inflorescence shoot meristem ([@bib31]), but these genes have not been functionally characterized ([@bib56]). In rice, *FLORAL ORGAN NUMBER 1* (*FON1*), the *CLV1* ortholog, and *FON2,* the *CLV3* ortholog, similarly function in floral development in a common pathway, as expected ([@bib78]; [@bib10]; [@bib79]; [@bib80]; [@bib77]), whereas a second rice CLE peptide gene, *FON2-LIKE CLE PROTEIN1 (FCP1)* controls stem cell proliferation independent of *FON1* ([@bib80]). The rice WUS homolog, *TILLERS ABSENT1*/*MONOCULM3* functions in axillary shoot meristem formation ([@bib82]; [@bib46]), and WUS function in the shoot apical meristems appears to have been taken over by the *WUSCHEL RELATED HOMEOBOX4* (*WOX4*) gene ([@bib63]).

How specificity is achieved is a common question in signal transduction pathways. Recently, we identified a distinct CLV receptor, *FASCIATED EAR3 (FEA3)* in maize and *Arabidopsis*, and found that FEA3 controls responses to the maize FCP1 (ZmFCP1) CLE peptide ([@bib31]). Here, we show that the maize CLV2 ortholog FEA2 also participates in ZmFCP1 signaling, in addition to controlling responses to the maize CLV3 ortholog, ZmCLE7 ([@bib31]). To ask how specificity from these different CLE peptide inputs is achieved, we first isolated mutant alleles of the maize *CRN* gene. Consistent with results in *Arabidopsis* ([@bib51]; [@bib54]; [@bib3]; [@bib89]; [@bib57]), we found that *fea2* was epistatic to *Zmcrn* in control of meristem size, but *Zmcrn;ct2* double mutants showed an additive enhanced phenotype, suggesting they act in parallel pathways, despite the fact that FEA2 binds both ZmCRN and CT2 in co-immunoprecipitation (co-IP) experiments. Strikingly, *ct2* and *Zmcrn* mutants were resistant to different CLE peptides, ZmCLE7 and ZmFCP1, respectively, but *fea2* was resistant to both, suggesting that FEA2 controls responses to different CLE peptides by acting through different downstream effectors.

Results {#s2}
=======

Both *fea3* and *fea2* mutants are resistant to the ZmFCP1 peptide {#s2-1}
------------------------------------------------------------------

We recently described a new CLE signaling pathway in maize, in which ZmFCP1 peptide signals through FEA3 to restrict ZmWUS1 expression from below its organizing center expression domain ([@bib31]). To test this model, we used a 2-component transactivation system ([@bib85]; [@bib31]) to drive ZmFCP1 expression in developing primordia, below the ZmWUS1 domain ([@bib31]; [@bib56]). As previously described, this expression reduced meristem size of wild type SAMs ([@bib31]), however we found that meristem size was only partially rescued when *ZmFCP1* expression was transactivated in a *fea3* mutant background ([Figure 1A and B](#fig1){ref-type="fig"}), suggesting that ZmFCP1 signals through additional receptors. We therefore conducted peptide response assays using *fea2* mutants, and found that they were also insensitive to ZmFCP1 peptide treatment, as well as to ZmCLE7, the maize CLV3 ortholog ([Figure 1C](#fig1){ref-type="fig"}) ([@bib31]). Interestingly, *fea2;fea3* double mutants restored the size of ZmFCP1 treated meristems to control levels, suggesting that ZmFCP1 signaling is transmitted predominantly through both FEA2 and FEA3 ([Figure 1D](#fig1){ref-type="fig"}). *fea3* mutants are resistant only to ZmFCP1, and not to ZmCLE7 ([@bib31]), so we next asked how FEA2 might transmit signals from different CLE peptides.

![Both *fea3* and *fea2* mutants are resistant to ZmFCP1 peptide.\
(**A**) Transactivation of ZmFCP1 in primordia using a pYABBY14:LhG4 driver led to a strong reduction in vegetative SAM size as compared to a non-transgenic control, but this effect was only partially rescued in a *fea3* mutant background; SAM diameter was quantified (**B**). In CLE peptide treatments, *fea2* mutants were resistant to ZmFCP1, as well as to ZmCLE7 (**C**), and *fea3;fea2* double mutants showed additive resistance to ZmFCP1, restoring SAM size to normal (**D**). Scale bars; 100 μm in A. n = 20 (**B, C**) and 30 (**D**) plants for each genotype. Data in B, C and D are shown by box plots. The mean values as well as the relative % to each untreated control are listed for each genotype. The untreated controls are set to 100%: \'\*\*\*\': P value \< 0.0001, two-tailed, two-sample t test. 'NS': not significant.\
10.7554/eLife.35673.004Figure 1---source data 1.CLE peptide treatments of *fea2;fea3* a segregating population.](elife-35673-fig1){#fig1}

*Zmcrn* mutants are fasciated {#s2-2}
-----------------------------

In maize, FEA2 signals through CT2, the alpha subunit of the heterotrimeric G protein ([@bib4]), but in *Arabidopsis* the FEA2 ortholog CLV2 is thought to signal through a membrane bound pseudokinase, CRN ([@bib51]; [@bib54]; [@bib3]; [@bib89]; [@bib57]). To ask if CRN also functions in CLV signaling in maize, we identified maize CRN (ZmCRN) by phylogenic analysis ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). As is the case for *Arabidopsis CRN*, *ZmCRN* was also predicted to encode an inactive pseudokinase ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) ([@bib7]; [@bib57]). We identified a predicted null allele as a *Mu* transposon insertion from the Trait Utility System in Corn (TUSC) resource ([@bib49]), 52 bp downstream of the predicted translation start site ([Figure 2A](#fig2){ref-type="fig"}). We backcrossed this *Mu* insertion line three times to the standard B73 inbred line, and dissected homozygous mutant or normal sib samples for meristem analysis. The maize *crn* (*Zmcrn*) mutants had larger vegetative shoot meristems (130.0 ± 4.1 μm, compared to 109.2 ± 4.6 μm for normal sibs, P value \< 0.0001, two-tailed t test, [Figure 2B and C](#fig2){ref-type="fig"}), and developed fasciated ear primordia with enlarged and split inflorescence meristems ([Figure 2D](#fig2){ref-type="fig"}), reminiscent of other *fasciated ear* mutants ([@bib81]; [@bib5]; [@bib4]; [@bib31]). Concurrently, we identified a second candidate allele by map-based cloning of a fasciated mutant, *fea\*148* ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), from an ethyl methyl sulfonate (EMS) screen in the B73 background (hereafter *Zmcrn-148*). *Zmcrn-148* introduced a stop codon within the predicted pseudokinase domain ([Figure 2A](#fig2){ref-type="fig"}), and plants homozygous for this mutation developed a similar fasciated ear phenotype ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). We next crossed heterozygous *Zmcrn-148* plants with *Zmcrn* mutants. The F1 plants developed fasciated ears, while *Zmcrn/+* or *Zmcrn-148 /+* heterozygotes had normal ear primordia, suggesting that these mutations were allelic ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), and confirming that *CRN* functions in shoot meristem size control in maize, similar to its role in *Arabidopsis. ZmCRN* was expressed throughout the SAM and more strongly in the peripheral domain and leaf primordia ([Figure 2E](#fig2){ref-type="fig"}, confirmed by laser capture microdissection RNAseq, [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Next, since *fea2* and other *fea* mutants are associated with quantitative variation in kernel row number (KRN) ([@bib6]), we took advantage of the identification of *ZmCRN* to ask if it was also associated with this yield trait. We conducted a candidate gene association study using a maize association panel of 368 diverse inbred lines ([@bib42]; [@bib44]). We found that three SNPs in the 3'UTR region of *CRN* showed significant association with KRN in multiple environments, below the threshold p-value\<0.001 ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"} and [Supplementary File 1](#supp1){ref-type="supplementary-material"}). These results suggest that natural variation in *ZmCRN* may underlie subtle variation in inflorescence meristem size sufficient to enhance KRN, with the potential to benefit maize yields.

![*Zmcrn* mutants develop fasciated ears.\
(**A**) Schematic of the *Zmcrn* mutant alleles. The arrows indicate the position of the Mutator transposon insertion and premature stop codon mutation. (**B**) Cleared SAMs from wild type (WT) and *Zmcrn* plants. The *Zmcrn* SAM has a larger diameter (double-headed arrows), SAM diameter was quantified (**C**). (**D**) Scanning electron microscopy images of WT and *Zmcrn* ear primordia (inflorescence meristems in yellow). The *Zmcrn* ear shows an enlarged and fasciated inflorescence meristem. (**E**) In-situ hybridization showing *ZmCRN* expression throughout the SAM, with higher expression in peripheral zone and leaf primordia. Scale bar: 100 μm in B and E, 500 μm in D. n = 30 (**C**) plants for each genotype. Data in C are shown by box plots. The mean values as well as the relative % to the WT control are listed. '\*\*\*\': P value \< 0.0001, two-tailed, two-sample t test.\
10.7554/eLife.35673.011Figure 2---source data 1.SAM size of *Zmcrn*in a segregating population.](elife-35673-fig2){#fig2}

*ZmCRN* and *FEA2* function in a common pathway {#s2-3}
-----------------------------------------------

In *Arabidopsis*, CRN is thought to signal downstream of CLV2 and correspondingly the double mutants show an epistatic interaction ([@bib54]). To ask if this relationship was conserved in maize, we measured the SAM size in a segregating double mutant population. As expected, both *Zmcrn* and *fea2* vegetative meristems were larger than normal (166.3 ± 8.3 μm, or 176.1 ± 9.8 μm respectively, compared to 139.7 ± 4.8 μm for normal sibs, P value \< 0.0001, two-tailed t test, [Figure 3A and B](#fig3){ref-type="fig"}), and the *Zmcrn; fea2* double mutants (177.2 ± 13.3 μm) were similar to the *fea2* single mutants (176.1 ± 9.8 μm, P value = 0.68, two-tailed t test) ([Figure 3A and B](#fig3){ref-type="fig"}). We also characterized ear inflorescence meristems and found that *fea2* had stronger fasciated ears than those of *Zmcrn*, but the double mutants resembled *fea2* single mutants ([Figure 3C](#fig3){ref-type="fig"}). Together, these results indicate that *fea2* is epistatic to *Zmcrn,* suggesting that *FEA2* and *ZmCRN* function in a common pathway in maize, as in *Arabidopsis*.

![ZmCRN acts in a common pathway with FEA2, but not with CT2.\
(**A**) Cleared SAMs from wild type (WT), *Zmcrn*, *fea2*, and *Zmcrn;fea2* double-mutant plants. SAMs from *Zmcrn* and *fea2* plants were significantly wider than in wild type (double-headed arrows), but SAM size was not significantly different between *fea2* and *Zmcrn;fea2* double mutants, SAM diameter was quantified (**B**). (**C**) Ear meristems of *fea2;Zmcrn* double mutants resemble *fea2* single mutants. (**D**) Cleared SAMs from wild type, *Zmcrn*, *ct2*, and *Zmcrn;ct2* double-mutant plants. SAMs from *Zmcrn* and *ct2* plants were significantly wider than in wild type, and were additively increased in *Zmcrn;ct2* double mutants; SAM diameter was quantified (**E**). (**F**) *Zmcrn;ct2* double mutants had enhanced fasciation of ear primordia. Scale bars: 100 μm in A and D, 500 μm in C and F. n = 30 (**B, E**) plants for each genotype. Data in B and E are shown by box plots. The mean values as well as the relative % to the WT control are listed. '\*\*\*\': P value \< 0.0001, two-tailed, two-sample t test, \'NS': not significant.\
10.7554/eLife.35673.013Figure 3---source data 1.SAM size of *Zmcrn;fea2* in a segregating population.](elife-35673-fig3){#fig3}

*ZmCRN* and *CT2* function in different pathways {#s2-4}
------------------------------------------------

We next asked if *ZmCRN* and *CT2* function in the same or in different pathways, again by double mutant analysis. Both *Zmcrn* and *ct2* mutants had larger SAMs compared with their normal sibs (161.5 ± 10.6 μm, or 157.1 ± 11.8 μm respectively, compared to 139.7 ± 8.5 μm for normal sibs, P value \< 0.0001, two-tailed t test, [Figure 3D and E](#fig3){ref-type="fig"}), but the SAMs of double mutants were significantly larger than each single mutant (191.8 ± 18.6 μm, P value \< 0.0001, two-tailed t test, [Figure 3D and E](#fig3){ref-type="fig"}), suggesting an additive interaction. *Zmcrn; ct2* double mutant ear inflorescences also showed additive enhancement in fasciation, compared to each single mutant ([Figure 3F](#fig3){ref-type="fig"}), confirming the additive interaction between *ct2* and *Zmcrn*. In summary, double mutant analyses and quantification of meristem sizes indicated that *ZmCRN* functions in the same pathway as *FEA2* and, as previously reported, *CT2* also functions in the same pathway as *fea2* ([@bib4]), but *CT2* and *ZmCRN* themselves function in different pathways. This result is most easily explained by the hypothesis that *FEA2* functions in two different pathways, one with *CT2* and a second with *ZmCRN.*

FEA2 interacts physically with CT2 and with ZmCRN {#s2-5}
-------------------------------------------------

To test the two-pathway hypothesis, we tested protein-protein interactions using Co-IP assays. We used an internal YFP fusion of CT2 that we previously found to be biologically active ([@bib4]), and C terminal mCherry or Myc fusions of ZmCRN or FEA2, respectively, which are predicted to be correctly localized and active, based on similar fusions ([@bib3]; [@bib60]). We first confirmed the expected plasma membrane localization of ZmCRN-mCherry by transient expression and plasmolysis ([Figure 4A](#fig4){ref-type="fig"}), consistent with FEA2 and CT2 localization ([@bib4]). ZmCRN-mCherry also co-localized with FEA2-YFP and CT2-YFP on the plasma membrane when they were co-expressed ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We then tested pairwise interactions using Co-IP experiments following transient expression. ZmCRN-mCherry was able to pull down FEA2-Myc, but not CT2-YFP, even when FEA2-YFP was also co-expressed ([Figure 4B](#fig4){ref-type="fig"}). We confirmed that CT2-YFP was properly expressed, because it could pull down FEA2-Myc ([Figure 4C](#fig4){ref-type="fig"}), as previously demonstrated by *in vivo* co-IPs ([@bib4]). To validate these interactions, a reciprocal Co-IP experiment was carried out, in which all three proteins were co-expressed, and we consistently found that FEA2-Myc could IP CT2-YFP or ZmCRN-mCherry ([Figure 4D](#fig4){ref-type="fig"}), further confirming that FEA2 formed complexes with both CT2 and ZmCRN. As an independent test, we also used an optimized BiFC system, with monomeric Venus (mVenus) split at residue 210 to reduce background due to false positive interactions ([@bib25]). We detected YFP signal when FEA2 fused with the N terminal part of mVenus (NmVen210) was co-expressed with ZmCRN fused with the C terminal part (CmVen210) ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming a direct interaction between FEA2 and ZmCRN. Similar results were reported in Arabidopsis using BiFC to detect CRN-CLV2 interactions ([@bib89]). However, we failed to detect a YFP signal when FEA2-NmVen210 was co-expressed with CT2-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The interaction between FEA2 and CT2 is well documented in maize by in vivo Co-IP experiments ([@bib4]), and a failure to detect the same interaction using BiFC suggests that their interaction might be indirect, such as in a complex where their interaction is bridged by other protein(s). Lastly, as expected, no signal was detected when CT2-NmVen210 was co-expressed with ZmCRN-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming out Co-IP results, and supporting the hypothesis that they do not interact. The FEA2-ZmCRN and FEA2-CT2 interactions appeared to be quite stable, and were not affected by co-infiltration of CLE peptides ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}).

![FEA2 is present in two different complexes.\
(**A**) ZmCRN-mCherry was localized at the plasma membrane following tobacco transient expression (top), and in subsequent plasmolysis (bottom). In transient expression followed by immunoprecipitation (IP) assay, ZmCRN-mCherry could IP FEA2-Myc, but not CT2-YFP (**B**), however CT2-YFP was able to IP FEA2-Myc, as expected (**C**). FEA2-Myc could also IP ZmCRN-mCherry and CT2-YFP, respectively (**D**). Scale bar: 20 μm in A.](elife-35673-fig4){#fig4}

In summary, the FEA2 receptor-like protein interacted with both candidate signaling molecules, ZmCRN and CT2, but these interactions appeared to be in different protein complexes, rather than in a common complex, because ZmCRN was not able to immunoprecipitate CT2.

*ct2* and *Zmcrn* show differential sensitivity to ZmCLE7 and ZmFCP1 peptides {#s2-6}
-----------------------------------------------------------------------------

The activity of CLE peptides can be assayed using synthetic peptide treatments, which suppress the growth of the SAM and root apical meristem ([@bib29]; [@bib39]). We therefore tested the sensitivity of each mutant to different CLE peptides, using embryo culture, as previously described ([@bib4]; [@bib31]). *ct2* or *Zmcrn* segregating populations were grown in the presence of different peptides, and shoots fixed and cleared for SAM measurements after 12 days. We found that *ct2* mutants were partially resistant to ZmCLE7, but not to ZmFCP1 peptide ([Figure 5A and B](#fig5){ref-type="fig"}), suggesting that CT2 functions specifically in signaling by ZmCLE7, the maize CLV3 ortholog. In contrast, we found that *Zmcrn* mutants were partially resistant to ZmFCP1, but not to ZmCLE7 ([Figure 5C and D](#fig5){ref-type="fig"}), suggesting that ZmCRN functions specifically in a ZmFCP1 signaling pathway. To confirm these results, we treated each mutant with both ZmCLE7 and ZmFCP1 together. We found that only *fea2,* but not *ct2 or Zmcrn* mutants, showed resistance to the double peptide treatment ([Figure 5E and F](#fig5){ref-type="fig"}). Together, these results suggest that FEA2 functions in both ZmCLE7 and ZmFCP1 signaling pathways, but CT2 and ZmCRN function specifically in ZmCLE7 or in ZmFCP1 signaling, respectively. As FEA3 also acts to transmit the ZmFCP1 signal ([@bib31]), we used genetic analysis to ask if ZmCRN also functions downstream of FEA3. In a segregating double mutant population, the SAMs of *Zmcrn* and *fea3* mutants were both larger than normal, as expected (160.2 ± 6.7 μm, or 176.8 ± 8.2 μm respectively, compared to 142.6 ± 6.0 μm for normal sibs, P value \< 0.0001, two-tailed t test), and the *fea3; Zmcrn* double mutants were larger than the single mutants (221.5 ± 21.2 μm, P value \< 0.0001, two-tailed t test), suggesting that FEA3 and ZmCRN do not function in a common pathway ([Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). Similar findings were observed for *fea3; ct2* double mutants ([Figure 5---figure supplement 1C and D](#fig5s1){ref-type="fig"}), suggesting that FEA3 and CT2 also do not function in a common pathway. Thus, ZmFCP1 signaling appears to be mediated by two different pathways, one acting through FEA2 coupled with ZmCRN, and another acting through FEA3 working through as yet unknown downstream component (s).

![*ct2* and *Zmcrn* show different sensitivity to ZmCLE7 and ZmFCP1 peptides.\
Embryos of each genotype were cultured with control, scrambled peptide (sCLV3) or with ZmFCP1 or ZmCLE7. Wild type SAM growth (double-headed arrows) was strongly inhibited by all peptides except sCLV3, and *ct2* growth was insensitive only to ZmCLE7 peptide (**A**), whereas *Zmcrn* was partially resistant only to ZmFCP1 peptide (**C**); SAM diameter was quantified (**B, D**). In treatments with both ZmFCP1 and ZmCLE7, only *fea2* showed resistance, but *Zmcrn* or *ct2* did not (**E, F**). Scale bars: 100 μm in A, C and E. N = 25 (**C**) plants for each genotype. Data in B, D and F are shown by box plots. The mean values as well as the relative % to each negative control are listed. '\*\*\*\': P value \< 0.0001, two-tailed, two-sample t test, 'NS': not significant.\
10.7554/eLife.35673.023Figure 5---source data 1.ZmFCP1 and ZmCLE7 double peptide treatments inct2,Zmcrnandfea2in a segregating population.](elife-35673-fig5){#fig5}

In summary, through identification of maize *crn* mutants, we were able to show that signaling through FEA2 by two different CLE peptides is differentiated using different candidate downstream signaling components; with the ZmCLE7 signal passing through CT2 and the ZmFCP1 signal passing through ZmCRN ([Figure 6](#fig6){ref-type="fig"}).

![Hypothetical model for FEA2 signaling through two different pathways.\
Two different peptides, ZmFCP1 and ZmCLE7, are proposed to bind to two separate FEA2 receptor complexes, and the two signals are differentially transmitted to downstream components; with the ZmCLE7 signal passing through CT2, and the ZmFCP1 signal passing through ZmCRN.](elife-35673-fig6){#fig6}

Discussion {#s3}
==========

A major question in signal transduction is how multiple inputs can be translated into distinct outputs. CLV-WUS feedback signaling is the central regulatory pathway in shoot meristem development, and perception of CLV3 peptide involves the CLV1 receptor-like kinase and the CLV2 receptor-like protein together with the CRN pseudokinase ([@bib8]; [@bib69]; [@bib51]; [@bib54]; [@bib3]; [@bib89]; [@bib57]). However, genetic evidence in both maize and *Arabidopsis* suggests these receptors function independently, and CLV2, and its maize ortholog FEA2, respond to multiple CLE peptides ([@bib5]; [@bib21]; [@bib54]; [@bib26]; [@bib50]; [@bib31]; [@bib28]). So how is the information conferred by these different signals kept separate during transmission through a common receptor?

To address this question and further decipher the FEA2 signaling pathway, we isolated mutants in the maize *CRN* ortholog, *ZmCRN,* by reverse genetics and by cloning a newly identified fasciated ear mutant *fea\*148. ZmCRN* was predicted to encode a membrane localize pseudokinase, like *CRN* in *Arabidopsis* ([@bib57]), and characterization of the mutants indicated that *ZmCRN* similarly functioned as a negative regulator of stem cell proliferation. We found that *fea2* was epistatic to *Zmcrn* and that FEA2 and ZmCRN interacted directly, using Co-IP and BiFC assays of proteins transiently overexpressed in *N. benthamiana*, suggesting that ZmCRN is a signaling component in the FEA2 pathway. Natural variation in the CLV-WUS pathway underlies yield improvements in different crop species including tomato, maize and mustard ([@bib6]; [@bib20]; [@bib86]; [@bib31]), and FEA2 is a quantitative trait locus (QTL) for kernel row number (KRN) ([@bib6]). In this study, we used a maize association panel of 368 diverse inbred lines to show that *ZmCRN* also had significant association with KRN under multiple environments ([@bib42]; [@bib44]), suggesting that *ZmCRN* contributes to quantitative variation in this trait. Therefore, ZmCRN could be manipulated for maize yield enhancement.

Previously, we identified the alpha subunit of the heterotrimeric G protein, CT2, as an additional interactor of FEA2. *fea2* is epistatic to *ct2* in meristem regulation, similar to its genetic interaction with *Zmcrn*, and FEA2 interacts with CT2 *in vivo*, revealing that *CT2*, like *ZmCRN*, is a candidate downstream signaling component of *FEA2* ([@bib4]). Although *fea2* was epistatic both to *ct2* and to *Zmcrn*, we found that *ct2; Zmcrn* double mutants had an additive interaction, suggesting they function in parallel, and that the FEA2 signaling pathway branches into these two different downstream signaling components. This idea was supported by peptide assays in different mutants, which suggested that ZmCRN and CT2 function specifically in ZmFCP1 or ZmCLE7 signaling, respectively, while FEA2 is involved in both. Although we used high peptide concentrations, the activity of CLE peptides is known to be enhanced by triarabinosylation ([@bib64]; [@bib47]; [@bib86]; [@bib13]), and indeed we found that similarly modified ZmCLE7 peptide was about 10 fold more potent than the non-modified form ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

Consistently with our findings, *ZmCRN*, *CT2* and *FEA2* were expressed broadly in the SAM in overlapping domains ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}). These data suggest a novel mechanism in plant receptor signaling, where a single receptor, FEA2, can transmit signals from two different CLE peptides, ZmFCP1 and ZmCLE7, through two different downstream components, ZmCRN and CT2. We thereby shed light on how distinct signaling by different peptides can be achieved through a common receptor. As a candidate receptor or co-receptor for different peptides, FEA2 does not have any close homologs in the maize genome ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), similar to CLV2 in Arabidopsis, and the relatively mild phenotype of *fea2* mutants may be due to compensation by partially redundant parallel signaling pathways, such as through FEA3 ([@bib31]). Our results are largely consistent with findings in Arabidopsis, that CRN is dispensable for CLV3 perception and signaling ([@bib60]), and that CLV2/CRN can function with other CLE ligand-receptor complexes ([@bib28]). However, in Arabidopsis CRN is required for CLV2 trafficking to the plasma membrane ([@bib3]). Our results suggest that the maize CLV2 ortholog FEA2 still functions (with CT2) in a *crn* mutant, so is presumably on the plasma membrane even in the absence of ZmCRN.

How then can a single receptor recognize different signals and transmit them differentially? The most obvious answer depends on the hypothesis that FEA2 and CLV2 are co-receptors that function with LRR RLKs, which binds CLE peptides directly ([Figure 6](#fig6){ref-type="fig"}). This hypothesis is supported by the finding that CLV1 binds CLV3 with high affinity, but CLV2 is unable to bind CLE peptides ([@bib70]), and that CLV2/CRN can function with different CLE ligand-receptor complexes ([@bib28]). There are conflicting results surrounding the interaction between CLV2 and CLV1; some experiments detect their physical interaction, but many of them use over-expression and are prone to false positive results, and *clv2* and *clv1* act additively in double mutant combinations ([@bib36]; [@bib54]). This genetic result suggests they act separately, and the same is true for the orthologs *FEA2* and *TD1* in maize ([@bib5]). A possible explanation for these conflicting findings is that CLV2 may act with multiple CLE receptor RLKs. This model is supported by the observation that CLV1 homologs, the BAMs, function redundantly with CLV1, so multiple LRR RLKs do indeed function in meristem size control. This also explains why all intermediate and strong *clv1* alleles are dominant negative, as they likely interfere with the activity of other receptor kinase(s) that have functional overlap with *CLV1* ([@bib18]; [@bib59]).

Despite not knowing the details of specific CLE-receptor interactions, our data show that FEA2 can transmit different peptide signals through two distinct downstream signaling components that most likely converge on the regulation of *ZmWUS* expression to regulate stem cell proliferation in meristem development ([Figure 6](#fig6){ref-type="fig"}). This suggests a new working model for meristem size regulation, in which ligand binding can be transmitted by a common co-receptor working with different RLKs coupled to distinct signaling proteins. Our model differs from most well-studied ligand-receptor signaling pathways, in which the signaling pathways usually converge ([@bib14]). For instance, different microbial ligands such as flagellin and Elongation Factor Thermo unstable (EF-Tu) are specifically recognized by the FLAGELLIN-SENSITIVE 2 (FLS2)-BRI1 ASSOCIATED RECEPTOR KINASE (BAK1) or EF-Tu RECEPTOR (EFR)-BAK1 RLK complexes, respectively, while signal transduction requires a shared set of cytosolic kinases, including BOTRYTIS-INDUCED KINASE 1 (BIK1) ([@bib1]; [@bib45]). Nevertheless, a similar principle can be drawn from the different signaling pathways mediated by BAK1, which functions as a co-receptor for the brassinosteroid (BR) receptor, BR INSENSITIVE 1 (BRI1) or for FLS2. After ligand perception, BR signaling through the BAK1-BRI1 complex is transmitted through the receptor-like cytoplasmic kinase (RLCK) BRASSINOSTEROID-SIGNALING KINASE 1 (BSK1), and flagellin signaling through the BAK1-FLS2 complex is transmitted through a different RLCK, BIK1 ([@bib43]; [@bib55]; [@bib9]; [@bib45]; [@bib84]; [@bib76]). Our study also reveals another source of variation in meristem receptor signaling, by highlighting the role of an additional CLE peptide, ZmFCP1. The role of FCP1 in meristem maintenance has been characterized in both maize and rice ([@bib80]; [@bib31]), but not yet in *Arabidopsis*.

In summary, multiple receptor signaling pathways appear to be required to for the perception of different CLE peptide signals to fine tune meristem development. This complex system of multiple peptides, receptors and downstream components presumably confers robustness on the meristem structure, as well as providing flexibility to control meristem development according to different physiological or developmental cues. For example, meristem size responds to stress and developmental transitions, such as floral induction, and different signaling pathways may confer such responsiveness. Our results help explain how meristem size regulation is orchestrated by multiple CLE peptides and receptors, as observed in many species including Arabidopsis, rice, maize and tomato ([@bib29]; [@bib75]; [@bib77]; [@bib59]; [@bib86]). They also support the idea that meristem signaling components are highly conserved between diverse plant species, and a major challenge is to understand how differential regulation of these common components leads to diversity in meristem organization and size across diverse plant taxa.

Materials and methods {#s4}
=====================

Plant growth and map based cloning {#s4-1}
----------------------------------

Maize plants were grown in the field or in the greenhouse. The *Zmcrn Mu* insertion allele was isolated from TUSC lines and was backcrossed three generations to the standard B73 inbred line. The *fea\*148* allele was isolated in an EMS mutagenesis screen using F2 seed stocks prepared by Prof. Gerald Neuffer, derived from a cross of mutagenized B73 pollen onto A619 ears. One fasciated plant from the segregating *fea\*148* M2 population from the maize GDB stock center was crossed to the A619 inbred, then selfed to make an F2 segregating population. Pooled DNAs from \~50 mutants or the same number of normal ear plants screened from the segregating F2 population were used for bulked segregant analysis (BSA) using a maize SNP50 chip (Illumina, Inc.). The BSA analysis revealed a clear linkage of the mutation on Chromosome 3 at 153--158 Mbp. As *ZmCRN* was an obvious candidate gene within the region, we sequenced the locus of *ZmCRN* using the mutant pool DNA and found a C to T mutation in the pseudokinase domain, which led to an early stop codon.

To measure meristem size, segregating siblings were genotyped and shoot apices of 7-day-old plants ([Figure 2B](#fig2){ref-type="fig"}) or 21-day-old plants ([Figure 3A and D](#fig3){ref-type="fig"}) were dissected, cleared and measured as described previously ([@bib81]). Measurement was made blindly without the knowledge of the genotypes. All measurements included at least 10 samples of each genotype, and two or three independent biological replicates, and mean values ± s.d. were presented, with significance calculated using two-tailed, two-sample *t* tests, and significant differences reported as *P* values.

Imaging {#s4-2}
-------

Scanning electron microscopy was performed on fresh tissues of maize using a Hitachi S-3500N SEM, as described ([@bib81]). For confocal microscopy, tobacco infiltrated tissues were dissected and images were taken with a Zeiss LSM 710 microscope, using 561 nm laser excitation and 580--675 nm emission for detection ZmCRN-mCherry, using 512 nm laser excitation and 518--538 nm emission for detection of CT2-YFP and FEA2-YFP and for BiFC imaging. For plasmolysis of ZmCRN-mCherry, leaf tissues were incubated for 30 min with 800 mM mannitol and imaged.

Double mutant analysis and in situ hybridization {#s4-3}
------------------------------------------------

Double mutants were constructed by crossing mutants introgressed into B73, followed by selfing or backcrossing to the F1. All plants were subsequently genotyped (primers are listed in Supplementary file 2). In situ hybridization experiments were performed as described ([@bib30]). Antisense and sense RNAs for *ZmCRN* were transcribed and used as probes. Primers are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Protein expression and Co-IP assays {#s4-4}
-----------------------------------

*CT2-YFP*, *ZmCRN-mCherry*, or *FEA2-Myc* expression constructs were infiltrated into 4-week-old *Nicotiana benthamiana* leaves together with a P19 plasmids to suppress posttranscriptional silencing ([@bib53]). The protein extraction and membrane fraction enrichment were described in [@bib4]. Briefly, the infiltrated leaves were harvested 3-d post infiltration. The leaf tissues were ground in liquid nitrogen to a fine powder then suspended in twice the volume of protein extraction buffer containing 150 mM NaCl, 50 mM Tris-HCl pH 7.6, 5% glycerol, and EDTA-free Protease inhibitor cocktail (Roche). After filtration through Miracloth, and centrifugation at 4,000 g for 10 min at 4°C, the extract was centrifuged at 100,000 g for 1 hr at 4°C to enrich the microsomal membrane fraction. The resulting pellet was re-suspended in the extraction buffer supplemented with 1% Triton X-100. Lysates were cleared by centrifugation at 100,000 g for 30 min at 4°C to remove non-solubilized material. ZmCRN-mCherry was immunoprecipitated using RFP-Trap (Chromotek) in membrane solubilization buffer for 40 min followed by washing 3 times with 1 ml of the same buffer. The IP'd proteins were eluted with 50 μl 1xSDS loading buffer at 95°C, followed by standard SDS-PAGE electrophoresis and western blotting. FEA2-Myc was immunoprecipitated using agarose beads conjugated with anti-Myc antibody (Millipore, 16--219, RRID:[AB_390197](https://scicrunch.org/resolver/AB_390197)). ZmCRN-mCherry was detected using an anti-RFP antibody (Rockland, 600-401-379, RRID:[AB_2209751](https://scicrunch.org/resolver/AB_2209751)), FEA2-Myc was detected using an anti-Myc antibody (Millipore, 05--724, RRID:[AB_309938](https://scicrunch.org/resolver/AB_309938)), and CT2-YFP was detected using an anti-GFP antibody (Roche, 11814460001, RRID:[AB_390913](https://scicrunch.org/resolver/AB_390913)).

Peptide assays {#s4-5}
--------------

Maize embryos segregating for each mutant were dissected at 10 days after pollination, when the SAM was exposed, and cultured on gel media ([@bib4]) containing scrambled peptide (30 μM; Genscript) or ZmFCP1 peptide or ZmCLE7 peptide or a mixture of ZmCLE7 and ZmFCP1 peptides ([@bib31]). After 12 days, the tissues were harvested for genotyping and the embryos were fixed in FAA (10%, formalin, 5% acetic acid, 45% ethanol) and cleared in methyl salicylate, and SAMs measured by microscopy, as described ([@bib31]). Triarabinosylated peptides were synthesized as described ([@bib13]).

Two-components transactivation assay {#s4-6}
------------------------------------

The two-component transactivation assay was performed as described ([@bib31]), and the lines were backcrossed into the *fea3* mutant background. To measure meristem size, segregating siblings were genotyped and shoot apical meristems of 14-day-old plants ([Figure 1A](#fig1){ref-type="fig"}) were dissected, cleared and measured as described previously ([@bib81]).

Association analysis of the *ZmCRN* locus {#s4-7}
-----------------------------------------

The candidate gene association analysis of *ZmCRN* with the kernel row number (KRN) trait was conducted in a maize association panel with 368 diverse inbred lines ([@bib42]). 22 SNPs in the *ZmCRN* gene region were observed based on previously released genotypes in the association panel. This was combined with KRN phenotypic data from five environments and BLUP (Best Linear Unbiased Prediction) data, including in Ya'an (30°N, 103°E), Sanya (18°N, 109°E) and Kunming (25°N, 102°E) in 2009 and Wuhan (30°N, 114°E) and Kunming (25°N, 102°E) in 2010 ([@bib44]). The association between *ZmCRN* and KRN was established by a mixed linear model corrected by population structure, with p-value\<0.001 as threshold ([@bib88]; [@bib42]).

Phylogenetic analysis {#s4-8}
---------------------

CLAVATA2 and FASCIATED EAR2 orthologs from *Arabidopsis thaliana*, *Solanum lycopersicum*, *Zea mays*, *Oryza sativa*, and *Amborella trichopoda* were aligned using MUSCLE ([@bib19]; [@bib65]; [@bib40]; [@bib83]; [@bib2]; [@bib33]). This alignment was converted to a Hidden Markov Model (HMM) using HMMER3.1b2 (hmmer.org), and was used to identify sequences that bore homology within the genomes of these five species (e-value cutoff \<10e-3). These amino acid sequences were grouped using convex clustering in CLANS ([@bib24]), and sequences that did not cluster closely with the CLV2/FEA2 cluster were removed manually, followed by subsequent clustering; this was repeated until no sequences were identified as separate from the CLV2/FEA2 cluster. Initial phylogenetic analyses of these sequences revealed a clade of RLPs sister to the CLV2/FEA2 clade. This subset of RLP sequences was used to build two additional HMMs as described above (hmmer.org), one of which included only monocot RLP sequences. These two RLP HMMs were used to search the five focal genomes again. All of the sequences recovered using both RLP HMMs were combined with the refined subset identified with the CLV2/FEA2 HMM, and iteratively clustered using CLANS until no sequences were identified as separate from the CLV2/FEA2 cluster ([@bib24]). The final set of sequences, with any kinase domains removed, were aligned via MAFFT L-INS-I ([@bib34]; [@bib35]). Model selection was performed using PartitionFinder2 ([@bib41]) and phylogenetic analysis under the maximum likelihood information criterion was performed using RAxML with the VT + I + G model and 1000 bootstrap replicates ([@bib74]). Signal peptide and transmembrane domains were identified using Phobius, and the presence of a kinase domain was determined using HMMER3.1b2 and the Pkinase domain, respectively ([@bib37]; [@bib22]; hmmer.org).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"The CLAVATA receptor FASCIATED EAR2 responds to distinct CLE peptides by signaling through two downstream effectors\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Senior/Reviewing Editor.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work cannot be considered for publication in *eLife* without substantial improvements that go much beyond a simple round of revisions.

The reviewers all agree that your manuscript presents an interesting story. The concept emerging from your work is potentially exciting and important, however, in the opinion of the reviewers and editors, it is not yet supported rigorously by the data. To make the strong point you project here, a number of additional, crucial experiments would be required. This includes, for example, expression pattern analyses, double mutant analyses, independent protein-protein interaction verifications, or more realistic physiological conditions, like lower peptide concentrations. If you choose to substantially improve the manuscript along these lines, and comprehensively address the individual reviewer comments pasted below, we are however ready to take another look at a resubmitted manuscript.

*Reviewer \#1:*

An unresolved mystery in plant development concerns the developmental mechanisms whereby functional specificity can arise from the redundancy of receptors involved in controlling stem cell homeostasis in shoot meristems. This well written manuscript addresses this question, to describe how the maize CLV2 gene can interact with two distinct peptide ligands by associating with two distinct effectors, which presumably in different downstream signaling pathways. This makes a novel contribution to the field.

Introduction.

1\) The introduction should stipulate that no WUS function is yet demonstrated in maize, and that the CLV1 homolog does not have a demonstrated function in the maize SAM. The manuscript says: \"In maize, THICK TASSEL DWARF1 (TD1) and FEA2 are CLV1 and CLV2 orthologs, and function similarly to restrict SAM proliferation\" -- this is untrue -- TD1 mutations affect the inflorescence shoot meristems, but there is no evidence that TD1 restricts vegetative SAM size.

Results.

2\) Why is there no demonstration of ZmCRN RNA or protein accumulation in maize shoot meristems?

3\) A new maize mutation in ZmCRN is identified and characterized. The genetic data clearly demonstrate that FEA2/CLV2 is epistatic to both ZmCRN and CT2, and that ZmCRN and CT2 function in different pathways.

4\) Although the CT2 YFP fusion was shown previously to complement the mutant phenotype, no assays of FEA2 or CRN fusion protein function are provided. Although the data, derived from a heterologous system, are clear and indicate the FEA2/CLV2 can interact with both CT2 and ZmCRN -- while CT2 and ZmCRN do not form a complex in tobacco -- I wonder why these fusion proteins were not introduced into maize? This is not always trivial due to complex promoter issues, but should be explained.

5\) The data clearly show that FEA2 mutants are reduced in sensitivity to both the FCP and CLE7 peptides, CT2 shows reduced sensitivity to its presumptive ligand CLE7 (but not FCP1), and ZmCRN is reduced in sensitivity to FCP1 (its presumptive ligand), but is sensitive to CLE7. However, the legend to [Figure 5](#fig5){ref-type="fig"} describes *crn* mutants as insensitive to FCP1, whereas the text better describes this interaction as \"partially resistant\", since FEA3 is presumably intact and should be responding to applied FCP ligand. Best to fix this inconsistency between the descriptions in the legend and the manuscript text.

*Reviewer \#2:*

The manuscript by Je et al. reports genetic and phenotypic characterizations among the mutants of CLAVATA pathway in Maize. The authors isolated a loss-of-function allele of ZmCRN, and characterized its meristem phenotype with *fea2*, that lacks a functional CLV2 ortholog, *fea3*, an LRR-RLK previously reported by the same group, and *ct2*, a mutant in G-α. Together with a series of double mutant analysis, CLE peptide application experiments, and in plant Co-IP experiments in *N. benthamiana*, the authors conclude that FEA2 form a different receptor complex depending on the CLE peptide.

The manuscript brings an important insight into a key question in receptor signaling, \"how could a receptor recognizes and discriminates related yet different signals to activate specific response?\". At the same time, however, the data provided are rather slim, and this reviewer feels that such a major claim should come with solid and multi-faceted experimental data of high rigor. Specific comments are as the following:

Role of FEA3: The genetic interactions of FEA3 in FEA2-CT and FEA2-ZmCRN pathways needs to be addressed in order to evaluate the genetic interaction and peptide application data. Both *fea2* and *fea3* are resistant to ZmFCP1 peptide application ([Figure 1](#fig1){ref-type="fig"}). Because of this, partial sensitivity of Zmcrn mutants to ZmFCP1 ([Figure 5D](#fig5){ref-type="fig"}) may be mediated through FEA3. Peptide application on *fea3* Zmcrn double mutants would clarify this.

ZmCRN expression/localization patterns: Where is ZmCRN expressed? For ZmCRN to function via forming a heterodimer with FEA2, their expression domain should overlap within the SAM. The authors could generate transgenic lines expressing the FP-tagged CRN in maize (which I agree might be very difficult and takes time for maize), or at least the authors must show clear in situ hybridization data long with the FEA2 and CT2.

Subcellular co-localization in *N. benthamiana*: The authors show that ZmCRN-mCherry localizes to PM in tobacco leaf epidermis. Would ZmFEA2 and/or CT co-localizes with ZmCRN on the plasma membrane in tobacco?

Protein-protein interaction assays: The authors present only one type experiment (Co-IP) to conclude that FEA2 forms a separate complex with ZmCRN and CT2 depending on the ligands. The following experiments would strengthen the conclusion:

a\) Reciprocal Co-IP. The authors should reciprocally IP FEA2 and confirm that FEA2 indeed brings down BOTH CT2 and ZmCRN when three proteins are co-expressed. I think this experiment must be performed.

b\) Role of different peptides, ZmFCP1 and ZmCLE7, on receptor complex formation. This can be done by treating/infiltrating/co-expressing each peptide to the *N. benthamiana* leaves along with a pair-wise combination of receptors.

Alternative experimental approach to support the in planta Co-IP experiments. The authors could perform BiFC, split-Ub or other protein-protein interaction assays to strengthen their claim.

[Figure 4C](#fig4){ref-type="fig"}. The gel lanes appear spliced. This is not an accepted practice or data presentation.

Discussion, fourth paragraph (discussion about why *clv2* phenotype is weaker than *clv1*). A previous report (Diévart et al., 2003) shows that missense alleles of *clv1* act in a dominant-negative manner. Please include this into the Discussion.

*Reviewer \#3:*

The manuscript by Je et al. reports the reverse (and forward) genetic characterization of ZmCRN, the mays ortholog of CORYNE (CRN) in *Arabidopsis*. The authors provide compelling genetic evidence that, just like in *Arabidopsis*, CRN acts in a common pathway with the LRR receptor kinase CLV2 (FEA2 in Zm). The novel finding is that FEA2 can form complexes with either ZmCRN or the heterotrimeric G-protein α subunit ZmCT2. The phenotypes of ZmCRN and ZmCT2 are additive, suggesting that FEA2 can signal via two different down-stream components. Peptide resistance assays furthermore suggest that these different signaling complexes may form in response to the sensing of different CLE peptides, ZmCLE7 and ZmFCP1, respectively. Overall this is a well written manuscript which provides some novel insight into the CLE signaling pathway involved in plant stem cell maintenance. Since, I am not a maize geneticist, I will focus my review on a) the biochemical experiments presented in this study and b) on the discussion of these novel findings:

a\) I understand that it is very difficult to perform any co-IP experiments in maize and that for this reason a transient system was chosen. I would find it nevertheless appropriate to at least mention in the Discussion that the outlined interactions were assayed not with native-like protein levels but rather by strongly overexpressing CRN, FEA2 and CT2.

b\) Why are the peptide resistance assays done with such high peptide concentrations (30 μM)? Do the authors think that the binding affinities of the maize receptor complexes are much lower than in *Arabidopsis*? Or are there post-translational modifications missing from the synthetic peptides? Or are the peptides poorly taken up by the plant tissue?

c\) Based on their findings, the authors suggest FEA2/CLV2 as a co-receptor for several CLE peptide-sensing LRR receptor kinases. In terms of the presented as well as previously established genetics on FEA2/CLV2 this would only make sense, if indeed CLV2 function can be replaced by another co-receptor in vivo. I would appreciate if the authors could present here a sequence alignment of the known receptor-like proteins from maize. Are there sequence homologs for CLV2 in maize (there are no obvious homologs in *Arabidopsis*)?

10.7554/eLife.35673.031

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> The reviewers all agree that your manuscript presents an interesting story. The concept emerging from your work is potentially exciting and important, however, in the opinion of the reviewers and editors, it is not yet supported rigorously by the data. To make the strong point you project here, a number of additional, crucial experiments would be required. This includes, for example, expression pattern analyses, double mutant analyses, independent protein-protein interaction verifications, or more realistic physiological conditions, like lower peptide concentrations. If you choose to substantially improve the manuscript along these lines, and comprehensively address the individual reviewer comments pasted below, we are however ready to take another look at a resubmitted manuscript.

We appreciate the constructive criticisms and suggestions from the three expert reviewers. We have added new data to address all comments, including expression analysis of *ZmCRN, fea3;Zmcrn* double mutant analyses, independent protein-protein interaction verification and treatments with different peptide concentrations, to address the issues. This new data further supports our major conclusion, and the manuscript has been substantially revised accordingly.

> Reviewer \#1:
>
> \[...\] Introduction.
>
> 1\) The introduction should stipulate that no WUS function is yet demonstrated in maize, and that the CLV1 homolog does not have a demonstrated function in the maize SAM. The manuscript says: \"In maize, THICK TASSEL DWARF1 (TD1) and FEA2 are CLV1 and CLV2 orthologs, and function similarly to restrict SAM proliferation\" -- this is untrue -- TD1 mutations affect the inflorescence shoot meristems, but there is no evidence that TD1 restricts vegetative SAM size.

As suggested, we have added text to clarify that WUS has not been functionally characterized in maize, and also added information about rice WUS function:

"Two maize WUS orthologs, ZmWUS1 and ZmWUS2, were predicted by phylogenetic analysis, and a *ZmWUS1* reporter is expressed in the presumptive organizing center of the inflorescence shoot meristem (Je at al., 2016), but these genes have not been functionally characterized (Nardmann and Werr 2006). \[...\] The rice WUS homolog, *TILLERS ABSENT1/ MONOCULM3* functions in axillary shoot meristem formation (Tanaka et al., 2015; Lu et al., 2015), and WUS function in the shoot apical meristems appears to have been taken over by the *WUSCHEL RELATED HOMEOBOX4 (WOX4)* gene (Ohmori et al., 2013)"

As to whether these mutations affect SAM or inflorescence shoot meristems, this is a semantic point, since the inflorescence meristem is also a "SAM", as it is the shoot meristem at the apex of the inflorescence. In general, the fasciated mutations in maize do enlarge the vegetative SAM, but in a much less dramatic way. However, to clarify, we changed "SAM" to "inflorescence shoot meristem" in the Introduction ("... and function similarly to restrict inflorescence shoot meristem proliferation...").

> Results.
>
> 2\) Why is there no demonstration of ZmCRN RNA or protein accumulation in maize shoot meristems?

In the revised manuscript, we now show expression of *ZmCRN* byin situ hybridization in maize shoot meristems. *ZmCRN* was expressed throughout the SAM and more strongly in the peripheral domain and leaf primordia ([Figure 2E](#fig2){ref-type="fig"}). This profile is confirmed by laser capture microdissection RNAseq data for different domains of the SAM (data from Timmermans lab, available from MaizeGDB; https://maizegdb.org/). This new data is added as [Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}, and new text:

"*ZmCRN* was expressed throughout the SAM and more strongly in the peripheral domain and leaf primordia ([Figure 2E](#fig2){ref-type="fig"}, confirmed by laser capture microdissection RNAseq, [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"})."

> 3\) A new maize mutation in ZmCRN is identified and characterized. The genetic data clearly demonstrate that FEA2/CLV2 is epistatic to both ZmCRN and CT2, and that ZmCRN and CT2 function in different pathways.

Thanks for the positive comment!

> 4\) Although the CT2 YFP fusion was shown previously to complement the mutant phenotype, no assays of FEA2 or CRN fusion protein function are provided. Although the data, derived from a heterologous system, are clear and indicate the FEA2/CLV2 can interact with both CT2 and ZmCRN -- while CT2 and ZmCRN do not form a complex in tobacco -- I wonder why these fusion proteins were not introduced into maize? This is not always trivial due to complex promoter issues, but should be explained.

We indeed previously made pFEA2-FEA2-YFP transgenic maize plants, and saw clear FEA2-YFP signal on the plasma membrane in the inflorescence meristem (http://maize.jcvi.org/cellgenomics/geneDB_list.php. However, we didn't make the ZmCRN transgenic plants, as the reviewer points out this is costly and time consuming. However, as requested by reviewer 2, we have added evidence of the plasma membrane localization of ZmCRN and additional support for protein-protein interactions, by performing reciprocal Co-IP and BiFC. These data were added in the revised manuscript ([Figure 4D](#fig4){ref-type="fig"}, Figure supplement 6 and Figure supplement 7). These additional assays give us extra confidence in the plasma membrane localization of ZmCRN and interactions between ZmCRN and FEA2, even though the experiments were carried out in *N. benthamiana*. Please note that we do not detect FEA2-CT2 direct interaction using BiFC, even though we have confirmed their interaction many times by in vivo co-IP, and we believe another protein is bridging their interaction (Q. Wu and DJ, unpublished).

"FEA2-YFP, ZmCRN-mCherry, CT2-YFP and ZmCRN-mCherry were also co-localized on the plasma membrane when they were co-expressed ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). \[...\] Lastly, as expected, no signal was detected when CT2-NmVen210 was co-expressed with ZmCRN-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming out co-IP results, and supporting the hypothesis that they do not interact."

> 5\) The data clearly show that FEA2 mutants are reduced in sensitivity to both the FCP and CLE7 peptides, CT2 shows reduced sensitivity to its presumptive ligand CLE7 (but not FCP1), and ZmCRN is reduced in sensitivity to FCP1 (its presumptive ligand), but is sensitive to CLE7. However, the legend to [Figure 5](#fig5){ref-type="fig"} describes crn mutants as insensitive to FCP1, whereas the text better describes this interaction as \"partially resistant\", since FEA3 is presumably intact and should be responding to applied FCP ligand. Best to fix this inconsistency between the descriptions in the legend and the manuscript text.

Thanks for catching this inconsistency. We reworded the [Figure 5](#fig5){ref-type="fig"} legend to "Zmcrn was partially resistant only to ZmFCP1 peptide" to make it consistent as suggested.

> Reviewer \#2:
>
> \[...\] Role of FEA3: The genetic interactions of FEA3 in FEA2-CT and FEA2-ZmCRN pathways needs to be addressed in order to evaluate the genetic interaction and peptide application data. Both fea2 and fea3 are resistant to ZmFCP1 peptide application ([Figure 1](#fig1){ref-type="fig"}). Because of this, partial sensitivity of Zmcrn mutants to ZmFCP1 ([Figure 5D](#fig5){ref-type="fig"}) may be mediated through FEA3. Peptide application on fea3 Zmcrn double mutants would clarify this.

We agree with the reviewer that it is important to understand the interaction between *FEA3* and *ZmCRN*, since both factors act to transmit the ZmFCP1 signal. We therefore added new data on the genetic interactions between *Zmcrn* and *fea3* (and also *ct2* and *fea3*) in double mutants. In the segregating double mutant population, the *fea3; Zmcrn* double mutants SAMs were larger than the single mutants,suggesting that FEA3 and ZmCRN do not function in a common pathway. Similar findings were observed for *fea3; ct2* double mutants. Thus, *fea3* acts additively with *Zmcrn*, suggesting that ZmFCP1 signaling is mediated by two parallel pathways, one through FEA3 working through an as yet unknown downstream component(s), and another through FEA2 coupled with ZmCRN. This genetic data largely supports the reviewer's speculation that the partial sensitivity of *Zmcrn* mutants to ZmFCP1 is mediated through FEA3. Importantly, our data suggest that *CT2* and *ZmCRN* do not act as downstream components for *FEA3*.

We have not performed peptide assays with the *fea3; Zmcrn* double mutants, since we just obtained them and it would take an additional 4-5 months to grow plants to make embryos and complete the treatments. We hope that the new data on *fea3; Zmcrn* double mutants is sufficient to convince the reviewer that *FEA3* and *ZmCRN* are acting in parallel, thus explaining the partial sensitivity of *Zmcrn* mutants to ZmFCP1 peptide.

These new data are presented in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"},and in the text:

"As FEA3 also acts to transmit the ZmFCP1 signal (Je et al., 2016), we used genetic analysis to ask if ZmCRN also functions downstream of FEA3. \[...\] Thus, ZmFCP1 signaling appears to be mediated by two different pathways, one acting through FEA2 coupled with ZmCRN, and another acting through FEA3 working through as yet unknown downstream component(s)."

> ZmCRN expression/localization patterns: Where is ZmCRN expressed? For ZmCRN to function via forming a heterodimer with FEA2, their expression domain should overlap within the SAM. The authors could generate transgenic lines expressing the FP-tagged CRN in maize (which I agree might be very difficult and takes time for maize), or at least the authors must show clear in situ hybridization data long with the FEA2 and CT2.

Thanks for understanding the difficulty and long time to make FP-tagged CRN transgenic plants. As also requested by reviewer 1, we carried out in situ hybridization with maize shoot meristems using a *ZmCRN* anti-sense probe. *ZmCRN* was expressed throughout the SAM and more strongly in the peripheral domain and leaf primordia ([Figure 2E](#fig2){ref-type="fig"}). This profile was confirmed by laser capture microdissection RNAseq data for different domains of the SAM (data from Timmermans lab, available from MaizeGDB; https://maizegdb.org/). This new data is added as [Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}. CT2 has been shown previously to express broadly in the SAM using CT2-YFP transgenic plants (Bommert et al., 2013a). In addition, laser capture RNA seq data showed that *FEA2, ZmCRN* and *CT2* are all expressed broadly in all domains of the SAM, suggesting that they are co-expressed ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}).

This new data is added as [Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}, and new text:

*"ZmCRN* was expressed throughout the SAM and more strongly in the peripheral domain and leaf primordia ([Figure 2E](#fig2){ref-type="fig"}, confirmed by laser capture microdissection RNAseq, [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"})."

> Subcellular co-localization in N. benthamiana: The authors show that ZmCRN-mCherry localizes to PM in tobacco leaf epidermis. Would ZmFEA2 and/or CT co-localizes with ZmCRN on the plasma membrane in tobacco?

Yes, we observed that FEA2 were co-localized with ZmCRN on the plasma membrane when these two proteins were co-expressed in *N. benthamiana* (Figure supplement 6). We also saw co-localization of CT2-YFP with ZmCRN-mCherry on plasma membrane when they are co-expressed ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}):

"FEA2-YFP, ZmCRN-mCherry, CT2-YFP and ZmCRN-mCherry were also co-localized on the plasma membrane when they were co-expressed ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"})."

> Protein-protein interaction assays: The authors present only one type experiment (Co-IP) to conclude that FEA2 forms a separate complex with ZmCRN and CT2 depending on the ligands. The following experiments would strengthen the conclusion:
>
> a\) Reciprocal Co-IP. The authors should reciprocally IP FEA2 and confirm that FEA2 indeed brings down BOTH CT2 and ZmCRN when three proteins are co-expressed. I think this experiment must be performed.
>
> Alternative experimental approach to support the in planta Co-IP experiments. The authors could perform BiFC, split-Ub or other protein-protein interaction assays to strengthen their claim.

As suggested, we performed the reciprocal Co-IPs and IPs using 3 co-expressed proteins. We had initially shown that either ZmCRN-mCherry or CT2-YFP could IP FEA2-myc, and now we added new experiments using 3 co-expressed proteins showing that when we reciprocally IP FEA2-myc we pull down CT2-YFP and ZmCRN-mCherry ([Figure 4D](#fig4){ref-type="fig"}), confirming that FEA2 indeed brings down both CT2 and ZmCRN when three proteins are co-expressed.

We also used bimolecular fluorescence complementation (BiFC) assays to independently confirm our in planta co-IPs. We used an optimized BiFC system, with monomeric Venus (mVenus) split at residue 210 to reduce background due to false positive interactions (Gookin et al., 2014). We detected YFP signal when FEA2 was fused with the N terminal part of mVenus (NmVen210) and ZmCRN was fused with the C terminal part (CmVen210) ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming a direct interaction between FEA2 and ZmCRN. Similar results were reported in *Arabidopsis* using BiFC to detect CRN-CLV2 interactions (Zhu et al., 2010). However, we failed to detect a YFP signal when FEA2-NmVen210 was co-expressed with CT2-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The interaction between FEA2 and CT2 is well documented in *N. benthamiana* as well as in maize by in vivo Co-IP experiments ([Figure 4C and 4D](#fig4){ref-type="fig"}, Bommert et al., 2013a). A failure to detect the same interaction using BiFC suggests that their interaction might be indirect ([Figure 6](#fig6){ref-type="fig"}). Our lab has extensively studied FEA2-CT2 interactions and repeated the in vivo co-IP many times, however in other experiments using FRET or BiFC we did not detect the interaction, suggesting the interaction is indirect, i.e. another protein or proteins bridges the interaction -- we are currently working on a candidate for this bridging protein.

Lastly, as expected, no signal was detected when CT2-NmVen210 was co-expressed with ZmCRN-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming out co-IP results, and supporting the hypothesis that they do not interact. This is described in the new text:

"To validate these interactions, a reciprocal Co-IP experiment was carried out, in which all three proteins were co-expressed, and we again found that FEA2-Myc could IP CT2-YFP or ZmCRN-mCherry ([Figure 4D](#fig4){ref-type="fig"}), further confirming that FEA2 formed complexes with both CT2 and ZmCRN. \[...\] Lastly, as expected, no signal was detected when CT2-NmVen210 was co-expressed with ZmCRN-CmVen210 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), confirming out co-IP results, and supporting the hypothesis that they do not interact."

> b\) Role of different peptides, ZmFCP1 and ZmCLE7, on receptor complex formation. This can be done by treating/infiltrating/co-expressing each peptide to the N. benthamiana leaves along with a pair-wise combination of receptors.

As suggested, we co-infiltrated ZmFCP1 or ZmCLE7 along with the expression of FEA2-Myc, CT2-YFP and CRN-mCherry, and performed the co-IP experiment. However, adding CLE peptides didn't affect the interaction between FEA2-myc and CT2-YFP or CRN-mCherry ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). This negative result is difficult to interpret, but we note that similar experiments have not been performed even in *Arabidopsis*, so there is no precedent to believe that the CLE ligands should lead to change in receptor complex formation. The results are described in the new text:

"Indeed, these interactions appeared to be quite stable, and they were not affected by co-infiltration of CLE peptides ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"})."

> [Figure 4C](#fig4){ref-type="fig"}. The gel lanes appear spliced. This is not an accepted practice or data presentation.

We apologize for the oversight, and inserted lines as suggested. The western blots are now presented in the correct way.

> Discussion, fourth paragraph (discussion about why clv2 phenotype is weaker than clv1). A previous report (Diévart et al., 2003) shows that missense alleles of clv1 act in a dominant-negative manner. Please include this into the Discussion.

Thanks. We added this information into the Discussion:

"This also explains why all intermediate and strong *clv1* alleles are dominant negative, as they likely interfere with the activity of other receptor kinase(s) that have functional overlap with CLV1 (Dievart et al., 2003; Nimchuk et al., 2015)."

> Reviewer \#3:
>
> \[...\] Overall this is a well written manuscript which provides some novel insight into the CLE signaling pathway involved in plant stem cell maintenance. Since, I am not a maize geneticist, I will focus my review on a) the biochemical experiments presented in this study and b) on the discussion of these novel findings:
>
> a\) I understand that it is very difficult to perform any co-IP experiments in maize and that for this reason a transient system was chosen. I would find it nevertheless appropriate to at least mention in the Discussion that the outlined interactions were assayed not with native-like protein levels but rather by strongly overexpressing CRN, FEA2 and CT2.

Thanks for the suggestion, we now mentioned in the Discussion part the caveat that the interaction between ZmCRN and FEA2 was carried out in a transiently overexpression system:

"...and that FEA2 and ZmCRN interacted directly, using Co-IP and BiFC assays of proteins transiently overexpressed in N. benthamiana, suggesting that ZmCRN is a signaling component in the FEA2 pathway."

In addition, in the revised manuscript, we provided more evidence on the interactions between ZmCRN and FEA2 using reciprocal Co-IP and BiFC in *N. benthamiana* ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). These data further confirm the interaction between FEA2 and ZmCRN. For the interaction between CT2 and FEA2, we also confirmed the interaction in *N. benthamiana* by reciprocal Co-IP experiments -- this interaction has been previously demonstrated using native expression in CT2-YFP transgenic maize (Bommert et al., 2013a). These new experiments are described in detail in the comments to reviewer 2, above.

> b\) Why are the peptide resistance assays done with such high peptide concentrations (30 μM)? Do the authors think that the binding affinities of the maize receptor complexes are much lower than in Arabidopsis? Or are there post-translational modifications missing from the synthetic peptides? Or are the peptides poorly taken up by the plant tissue?

As in our previous publications (Bommert et al., 2013a, Je et al., 2016), 5 -- 30 μM peptide have been routinely used for maize root and embryo assays, respectively. Of course, we cannot know how much peptide penetrates the tissues. One reason why such a high concentration is needed might be that the synthetic peptides lack necessary post-translational modifications; in *Arabidopsis*, CLV3 is arabinosylated on a hydroxyproline modified residue (Matsubayashi, 2011), and this post-translational modification is critical for its high-affinity binding to its receptor, CLV1 (Ohyama et al., 2009). In tomato, a mutant in a hydroxyproline O-arabinosyltransferase has enlarged shoot meristems, and the mutant can be rescued with arabinosylated CLV3 (Xu et al., 2015). Thus, CLE peptides with arabinosylated hydroxyproline modifications have higher activity than the non-modified peptides.

The tri-arabinosylated CLE peptides are not commercially available, and the group that first published them were not able to provide it to us because they are very difficult to produce. However, very recently we obtained some hydroxyproline-triarabinosyl modified ZmCLE7 peptide from a collaborator (similar to ones published in Corcilius et al., 2017). We compared maize root and SAM growth following treatment with modified or non-modified peptides. As predicted, the arabinosylated ZmCLE7 peptide was more potent than the non-modified version, we estimate by \~ 10 fold. However, our collaborator could only provide a small amount of the arabinosylated CLE7 peptide and it is not enough to repeat all of the assays in the manuscript. Therefore, we propose the following modification to the manuscript:

"Although we used high peptide concentrations, the activity of CLE peptides is known to be enhanced by triarabinosylation (Ohyama et al., 2009; Matsubayashi 2011; Xu et al., 2015; Corcilius et al., 2017), and indeed we found that similarly modified ZmCLE7 peptide was about 10 fold more potent than the non-modified form ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"})."

*c) Based on their findings, the authors suggest FEA2/CLV2 as a co-receptor for several CLE peptide-sensing LRR receptor kinases. In terms of the presented as well as previously established genetics on FEA2/CLV2 this would only make sense, if indeed CLV2 function can be replaced by another co-receptor* in vivo*. I would appreciate if the authors could present here a sequence alignment of the known receptor-like proteins from maize. Are there sequence homologs for CLV2 in maize (there are no obvious homologs in Arabidopsis)?*

We included a phylogenetic analysis supporting the idea that similar to CLV2 in *Arabidopsis*, FEA2 does not have any close homolog that could function redundantly in maize ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We think the reviewer is asking why then are *fea2* phenotypes not stronger. We believe this is because of other redundant pathways, such as *fea3*, as also discussed in our response to reviewer 2.

"As a candidate receptor or co-receptor for different peptides, FEA2 does not to have any close homologs in the maize genome ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), similar to CLV2 in *Arabidopsis*, and its relatively modest phenotype may be due to compensation by partially redundant parallel signaling pathways, such as through FEA3 (Je at al., 2016) in *fea2* mutants."

[^1]: These authors contributed equally to this work.
